Verified90% confidenceFactTime unknown
The FDA has a clear regulatory framework for AI-assisted medical decision-making tools, classifying them as Software as a Medical Device (SaMD).
8
Sources
90%
Confidence
Long-term
Relevance
6/1/2026
First Seen
Sources
Related Entities
Related Claims
Unverified医学AI产品被归类为医疗器械软件（SaMD），这一概念框架由国际医疗器械监管机构论坛（IMDRF）于2013年正式提出80% similarUnverified美国FDA在2021年发布的《AI/ML软件行动计划》中提出'预定变更控制计划'（Predetermined Change Control Plan）框架，要求AI辅助医疗决策工具提供完整证据链74% similarUnverifiedThe FDA chose to build its AI-ready data infrastructure on the Databricks for Government platform.74% similarUnverifiedSome digital health platforms adopt a human-machine collaboration model that combines AI recommendations with remote review by licensed physicians, or embeds hard constraint rules based on evidence-based medicine guidelines within the AI system.71% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/17817API
curl https://kongchang.com/api/v1/knowledge/claims/17817MCP
get_claim(id=17817)